News on noninvasive prenatal testing, carrier screening, and preimplantation genetic screening.
Under the agreement, the companies plan to develop a customized solution that can be widely deployed for DNA sequencing.
Cooper took a $24.4 million impairment charge in the second quarter on the intangible assets it acquired in 2016 from carrier screening firm Recombine.
Researchers from Stanford University reported in a pilot study that seven RNA transcripts could predict preterm birth.
The $375 million deal marks the integration of Myriad, a leader in the hereditary cancer genetic screening market, with Counsyl, a leader in reproductive genetic screening.
Myriad will merge Counsyl’s reproductive tests with its preventive care business unit into a new business unit called Myriad Women’s Health.
